
Novartis Maintains Growth Trajectory Amid Patent Challenges, Dividend Consistency
Novartis maintains growth despite patent challenges, backed by a strong product portfolio of 15 billion-dollar brands and nearly 30 years of consecutive dividend increases.
NVSdividend growthlong-term investing



